Pro Dex (PDEX) EBITDA Margin (2010 - 2026)
Pro Dex (PDEX) posted EBITDA Margin of 15.51% for Q1 2026, down 11.18% sequentially from 17.46% in Q4 2025, and down 539.0% YoY from 3.53% in Q1 2025.
Pro Dex (PDEX) EBITDA Margin (2010 - 2026) Analysis & Trends
Pro Dex has reported EBITDA Margin for 14 years, with the latest figure at 15.51% in Q1 2026.
- Quarterly EBITDA Margin fell 539.0% year-over-year to 15.51% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.48% (down 376.0% YoY) and the FY2025 annual result came in at 16.05%, up 273.0% from the prior year.
- EBITDA Margin retreated to 15.51% in Q1 2026 per PDEX's latest filing, from 17.46% in the prior quarter.
- Over five years, EBITDA Margin peaked at 20.9% in Q1 2025 and troughed at 6.17% in Q4 2023.
- A 5-year average of 13.95% and a median of 15.48% in 2024 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin surged 986 bps in 2024, then sank 796 bps in 2025.
- Over 5 years, EBITDA Margin stood at 10.08% in 2022, then tumbled by 39 bps to 6.17% in 2023, then soared by 160 bps to 16.03% in 2024, then rose by 9 bps to 17.46% in 2025, then dropped by 11 bps to 15.51% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 15.51%, 17.46%, and 16.78% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 33.60% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.31% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 0.39% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 30.66% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.14% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 20.53% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 8.19% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -2.87% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 7.33% |
| 10 | Pro Dex | 215.72 Mn | 204.74 Mn | 6.13 Mn | 15.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.51% |
| Dec 31, 2025 | 17.46% |
| Sep 30, 2025 | 16.78% |
| Jun 30, 2025 | 7.68% |
| Mar 31, 2025 | 20.90% |
| Dec 31, 2024 | 16.03% |
| Sep 30, 2024 | 20.23% |
| Jun 30, 2024 | 15.65% |
| Mar 31, 2024 | 15.48% |
| Dec 31, 2023 | 6.17% |
| Sep 30, 2023 | 15.35% |
| Jun 30, 2023 | 15.13% |
| Mar 31, 2023 | 15.79% |
| Dec 31, 2022 | 10.08% |
| Sep 30, 2022 | 8.57% |
| Jun 30, 2022 | 9.38% |
| Mar 31, 2022 | 11.02% |
| Dec 31, 2021 | 15.75% |
| Sep 30, 2021 | 13.20% |
| Jun 30, 2021 | 6.25% |